Wednesday, June 10, 2026

biotech · PTSD - Post Traumatic Stress Disorder · P1b: Advanced Solid Tumors · CMPX

Compass Therapeutics

News and analysis for Compass Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

80 Guest Street, Suite 601, Boston, MA 02135, US HQ
2014 Founded
54 Employees
Public company Type
CMPX · NYSE Ticker
Company details
Status
Public
HQ
80 Guest Street, Suite 601, Boston, MA 02135, US
Founded
2014
Employees
54
Programs
15
Drugs
3
Patents
100
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Compass Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Compass Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Compass Therapeutics yet.

Back to company overview →